Terms: = Brain cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID
106 results:
1. Regulatory T cells use heparanase to access IL-2 bound to extracellular matrix in inflamed tissue.
Martinez HA; Koliesnik I; Kaber G; Reid JK; Nagy N; Barlow G; Falk BA; Medina CO; Hargil A; Zihsler S; Vlodavsky I; Li JP; Pérez-Cruz M; Tang SW; Meyer EH; Wrenshall LE; Lord JD; Garcia KC; Palmer TD; Steinman L; Nepom GT; Wight TN; Bollyky PL; Kuipers HF
Nat Commun; 2024 Feb; 15(1):1564. PubMed ID: 38378682
[TBL] [Abstract] [Full Text] [Related]
2. The Association of Immune Cell Infiltration with Metastasis Location in De Novo Metastatic Triple Negative Breast cancer: A Multicenter Cross-Sectional Study in Indonesia.
Tenggara JB; Rachman A; Prihartono J; Lisnawati L; Panigoro SS; Heriyanto DS; Steven R; Tandarto K; Juanputra S; Sudoyo AW
Acta Med Indones; 2023 Oct; 55(4):376-384. PubMed ID: 38213050
[TBL] [Abstract] [Full Text] [Related]
3. Efficient 3D imaging and pathological analysis of the human lymphoma tumor microenvironment using light-sheet immunofluorescence microscopy.
Chen L; Meng J; Zhou Y; Zhao F; Ma Y; Feng W; Chen X; Jin J; Gao S; Liu J; Zhang M; Liu A; Hong Z; Tang J; Kuang D; Huang L; Zhang Y; Fei P
Theranostics; 2024; 14(1):406-419. PubMed ID: 38164148
[No Abstract] [Full Text] [Related]
4. cancer-associated fibroblasts-induced remodeling of tumor immune microenvironment via Jagged1 in glioma.
Zhang Q; Wang J; Zhang J; Wang Y; Wang Y; Liu F
Cell Signal; 2024 Mar; 115():111016. PubMed ID: 38128708
[TBL] [Abstract] [Full Text] [Related]
5. Differential requirements for CD4+ T cells in the efficacy of the anti-PD-1+LAG-3 and anti-PD-1+CTLA-4 combinations in melanoma flank and brain metastasis models.
Phadke MS; Li J; Chen Z; Rodriguez PC; Mandula JK; Karapetyan L; Forsyth PA; Chen YA; Smalley KSM
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38056899
[TBL] [Abstract] [Full Text] [Related]
6. Dietary L-Tryptophan consumption determines the number of colonic regulatory T cells and susceptibility to colitis via GPR15.
Van NT; Zhang K; Wigmore RM; Kennedy AI; DaSilva CR; Huang J; Ambelil M; Villagomez JH; O'Connor GJ; Longman RS; Cao M; Snook AE; Platten M; Kasenty G; Sigal LJ; Prendergast GC; Kim SV
Nat Commun; 2023 Nov; 14(1):7363. PubMed ID: 37963876
[TBL] [Abstract] [Full Text] [Related]
7. Autoimmune Limbic Encephalitis in Patients with Hematologic Malignancies after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide.
Heo BY; Lee MW; Choi S; Jung Y; Pham TTD; Jang Y; Park JH; Kang S; Koh JS; Jo DY; Kwon J; Song IC
Cells; 2023 Aug; 12(16):. PubMed ID: 37626859
[TBL] [Abstract] [Full Text] [Related]
8. Characterization of neural mechanotransduction response in human traumatic brain injury organoid model.
Beltrán SM; Bobo J; Habib A; Kodavali CV; Edwards L; Mamindla P; Taylor RE; LeDuc PR; Zinn PO
Sci Rep; 2023 Aug; 13(1):13536. PubMed ID: 37598247
[TBL] [Abstract] [Full Text] [Related]
9. Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis.
Lang A; Jeron RL; Lontzek B; Kiesel B; Mischkulnig M; Berghoff AS; Ricken G; Wöhrer A; Rössler K; Lötsch-Gojo D; Roetzer-Pejrimovsky T; Berger W; Hainfellner JA; Höftberger R; Widhalm G; Erhart F
J Neurooncol; 2023 Aug; 164(1):211-220. PubMed ID: 37543970
[TBL] [Abstract] [Full Text] [Related]
10. E-cadherin expression in the tumor microenvironment of advanced epidermal growth factor receptor-mutant lung adenocarcinoma and the association with prognosis.
Chang YP; Huang GK; Chen YC; Huang KT; Chen YM; Lin CY; Huang CC; Lin MC; Wang CC
BMC Cancer; 2023 Jun; 23(1):569. PubMed ID: 37340370
[TBL] [Abstract] [Full Text] [Related]
11. IL-33's role in the gut immune system: A comprehensive review of its crosstalk and regulation.
Kaur H; Kaur G; Ali SA
Life Sci; 2023 Aug; 327():121868. PubMed ID: 37330043
[TBL] [Abstract] [Full Text] [Related]
12.
Suzuki T; Takei J; Fukasawa N; Suzuki K; Ogawa D; Yamamoto Y; Akasaki Y; Murayama Y; Shimoda M; Miyake K; Tanaka T
World Neurosurg; 2023 Jul; 175():e1364-e1374. PubMed ID: 37187346
[TBL] [Abstract] [Full Text] [Related]
13.
Kim HS; Kim CG; Kim WK; Kim KA; Yoo J; Min BS; Paik S; Shin SJ; Lee H; Lee K; Kim H; Shin EC; Kim TM; Ahn JB
Front Cell Infect Microbiol; 2023; 13():1101291. PubMed ID: 36960042
[TBL] [Abstract] [Full Text] [Related]
14. The Single-Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and brain Metastases of Breast cancer.
Zou Y; Ye F; Kong Y; Hu X; Deng X; Xie J; Song C; Ou X; Wu S; Wu L; Xie Y; Tian W; Tang Y; Wong CW; Chen ZS; Xie X; Tang H
Adv Sci (Weinh); 2023 Feb; 10(5):e2203699. PubMed ID: 36529697
[TBL] [Abstract] [Full Text] [Related]
15. Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial.
Todo T; Ito H; Ino Y; Ohtsu H; Ota Y; Shibahara J; Tanaka M
Nat Med; 2022 Aug; 28(8):1630-1639. PubMed ID: 35864254
[TBL] [Abstract] [Full Text] [Related]
16. Gliosarcoma: The Distinct Genomic Alterations Identified by Comprehensive Analysis of Copy Number Variations.
Cheng CD; Chen C; Wang L; Dong YF; Yang Y; Chen YN; Niu WX; Wang WC; Liu QS; Niu CS
Anal Cell Pathol (Amst); 2022; 2022():2376288. PubMed ID: 35757013
[TBL] [Abstract] [Full Text] [Related]
17. The immunosuppressive role of indoleamine 2, 3-dioxygenase in glioblastoma: mechanism of action and immunotherapeutic strategies.
Hosseinalizadeh H; Mahmoodpour M; Samadani AA; Roudkenar MH
Med Oncol; 2022 Jun; 39(9):130. PubMed ID: 35716323
[TBL] [Abstract] [Full Text] [Related]
18. A comprehensive profiling of the immune microenvironment of breast cancer brain metastases.
Griguolo G; Tosi A; Dieci MV; Fineberg S; Rossi V; Ventura A; Bottosso M; Bauchet L; Miglietta F; Jacob J; Rigau V; Fassan M; Jacot W; Conte P; Rosato A; Darlix A; Guarneri V
Neuro Oncol; 2022 Dec; 24(12):2146-2158. PubMed ID: 35609559
[TBL] [Abstract] [Full Text] [Related]
19.
Liang L; Yan B; Liu Y; Jiang S; He H; Huang J; Liu W; Xie L
Dis Markers; 2022; 2022():4534080. PubMed ID: 35401877
[TBL] [Abstract] [Full Text] [Related]
20. STING agonist enhances the efficacy of programmed death-ligand 1 monoclonal antibody in breast cancer immunotherapy by activating the interferon-β signalling pathway.
Yin M; Hu J; Yuan Z; Luo G; Yao J; Wang R; Liu D; Cao B; Wu W; Hu Z
Cell Cycle; 2022 Apr; 21(8):767-779. PubMed ID: 35130108
[TBL] [Abstract] [Full Text] [Related]
[Next]
